Moyamoya Syndrome and Sickle Cell Anemia: A Clinical Report

Authors

  • Lúcia Proença Serviço de Medicina I, Hospital Professor Doutor Fernando Fonseca, EPE, Lisboa, Portugal
  • Marta Vaz Batista Serviço de Medicina I, Hospital Professor Doutor Fernando Fonseca, EPE, Lisboa, Portugal
  • Jandir Patrocínio Serviço de Medicina I, Hospital Professor Doutor Fernando Fonseca, EPE, Lisboa, Portugal
  • Rodrigo Moraes Serviço de Medicina I, Hospital Professor Doutor Fernando Fonseca, EPE, Lisboa, Portugal
  • Fernanda Louro Serviço de Medicina I, Hospital Professor Doutor Fernando Fonseca, EPE, Lisboa, Portugal
  • Marinela Major Serviço de Medicina I, Hospital Professor Doutor Fernando Fonseca, EPE, Lisboa, Portugal

DOI:

https://doi.org/10.24950/rspmi.738

Keywords:

Anemia, Sickle Cell, Moyamoya Disease, Sickle Cell Trait, Stroke

Abstract

Moyamoya syndrome is a rare clinical entity of unkown etiology
which is described in association with various diseases,
including sickle cell anemia. The authors present a case of a
28-year-old woman with known history of sickle-cell anemia,
two ischemic stroke episodes and long term hemiparesis,
seeks the emergency department due to worsening of the
left hemiparesis, with homolateral paresthesias and frontoparietal
headache. The physical examination confirmed the
neurologic deficit. Brain computed tomographyand angio-
-magnetic resonance imaging showed vascular abnormalities,
with bilateral internal carotid and medial cerebral artery
stenosis and small and entangled sublenticular vessels, suggesting
the moyamoya-like pattern. A diagnostic cerebral
angiography was performed, which confirmed this abnormal
vascular pattern. Conservative medical treatment was the
option in this particular case, taking into account the risks
involved in an invasive surgical procedure. “Moyamoya”
means, in japanese, “puff of smoke”, illustrating this a typical
angiographic vascular pathologic pattern. We intend not only
to describe this clinical case, but also to review the current
evidence about this rare clinical entity.

Downloads

Download data is not yet available.

References

Mineharu Y, Takenaka K, Yamakawa H, Inoue K, Ikeda H, Kikuta HI, et al. Inheritance pattern of familial moyamoya disease: autosomal dominant mode and genomic imprinting, J Neurol Neurosurg Psychiatry. 2006; 77: 1025-9.

Houkin K, Ito M, Sugyama T, Shichinohe H, Nakayama N, Kazumata K, et al. Review of past research and current concepts on the etiology of moyamoya disease. Neurol Med Chir. 2012; 52:267-77.

Scott RM, Smith ER, Moyamoya disease and moyamoya syndrome. N Engl J Med. 2009; 360;:1226-37.

Naik RP, Streiff M, Lanzkron S. Sickle cell disease and venous thromboembolism: what the anticoagulation expert needs to know. J Thromb Thrombolysis. 2013;35 :352-8

Swanwela NC. Moyamoya disease: etiology, clinical features, and diagnosis. UpToDate. 2016 [accessed March 2016] Available from: https://www.uptodate.com/contents/moyamoya-disease-etiology-clinical-features-and-diagnosissource=search_result&search=moyamoya%20etiology&selectedTitle=1~36.

Swanwela NC. Moyamoya disease: treatment and prognosis. UpToDate. 2016 [accessed March 2016] Available from: https://www.uptodate.com/contents/moyamoya-disease-treatment-and-prognosis?source=search_result&search=moyamoya%20treatment%20and%20prognosis&selectedTitle=1~36Aces

Additional Files

Published

2017-06-30

How to Cite

1.
Proença L, Vaz Batista M, Patrocínio J, Moraes R, Louro F, Major M. Moyamoya Syndrome and Sickle Cell Anemia: A Clinical Report. RPMI [Internet]. 2017 Jun. 30 [cited 2024 Nov. 23];24(2):124-7. Available from: https://revista.spmi.pt/index.php/rpmi/article/view/738

Issue

Section

Case Reports

Most read articles by the same author(s)